ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation.

R. Klasek,1 S. Kuten,1 S. Patel,1,3 D. Nguyen,1 E. Graviss,1 A. Gaber,1 R. Knight.1

1Houston Methodist Hospital, Houston, TX
2Veloxis Pharmaceuticals, Cary, NC

Meeting: 2017 American Transplant Congress

Abstract number: B112

Keywords: Graft function, Kidney/pancreas transplantation, Outcome, Pancreas transplantation

Session Information

Session Name: Poster Session B: Bacteria, Fungi, Parasites

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Previous studies have shown that approximately 20% of febrile episodes in transplant recipients are not associated with infection. At our center, fever of unknown origin (FUO) is a common cause for readmission following pancreas-alone (PA) and simultaneous pancreas-kidney (SPK) transplant. This study aimed to characterize the incidence and outcomes of pancreas recipients with FUO during the first post-transplant year. All PA and SPK recipients with functioning grafts transplanted from 01/2011 to 08/2015 were included. Diagnosis of FUO was based upon previously accepted criteria adapted from Durack et al.1 A total of 102 patients were reviewed and 92 included. Patients were on average 42 years old, and consisted of 51 (55%) male and 81 (88%) SPK recipients. Twenty-three (25%) patients experienced FUO resulting in 34 admissions, with median time to first FUO admission of 28 days post-transplant. Eight patients had multiple re-admissions for FUO. FUO accounted for 173 admission days with a median length of stay of 6 days. Evaluation of FUO consisted of blood/urine cultures (100%), CMV PCR (100%), chest x-ray (100%), non-head CT (78%), head CT (4%), MRI (9%), indium scan (22%) and lumbar puncture (4%). After ruling out infectious etiology, 17 patients were managed empirically with intravenous (IV) methylprednisolone (median dose 750 mg). Empiric treatment with IV methylprednisolone led to resolution of fever, but did not affect subsequent FUO readmission rates. Rates of documented infection and rejection at 1 year were similar in FUO and FUO-free patients (Table 1). In conclusion, FUO was common in pancreas transplants and was associated with frequent admissions, prolonged hospitalizations, and extensive diagnostic testing, though did not seem to be associated with detrimental infectious rates or graft outcomes at 1 year. Further study into risk factors and mechanism is warranted.1.Durack D, Street A. Fever of unknown origin–reexamined and redefined. In: Remington J, Swartz M, et al. Current clinical topics in infectious diseases. Volume 20. Blackwell Scientific Publications;1991;p:35–51.

CITATION INFORMATION: Klasek R, Kuten S, Patel S, Nguyen D, Graviss E, Gaber A, Knight R. The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Klasek R, Kuten S, Patel S, Nguyen D, Graviss E, Gaber A, Knight R. The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/the-incidence-and-outcomes-of-fever-of-unknown-origin-after-pancreas-transplantation/. Accessed May 25, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences